A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)
Clinical trial NCT01721746 · COMPLETED
Trial details
- NCT number
- NCT01721746
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-21
- Primary completion
- 2016-02-16
- Enrollment
- 405
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.